“…Follow-up images after 39 months showed a patent artery with no recurrence of any cystic lesions, highlighting successful ACD treatment via stenting, ultrasound-guided aspiration, and cyst drainage. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: Cardioembolism due to paroxysmal atrial fibrillation, patent foramen ovale, or cardiomyopathy; occult atherosclerosis from unstable plaques and hypercoagulable conditions seem to be the most common underlying causes to be revealed by further investigations. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Transient hypoglycemia, abnormal cranial magnetic resonance imaging, multiple nodules in polycystic kidneys and liver, abnormal hearing, patent ductus arteriosus, and an atrial septal defect were also noted. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The search was conducted in several databases, including scientific and patent databases. Pharmaceutical nanotechnology and medicinal chemistry are the tools of choice to achieve human applications, and most of these applications have been able to improve the biopharmaceutical properties and pharmacokinetic profile of DQ. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…LJF and LF are commonly used in Chinese patent drugs. In the Chinese Pharmacopoeia, LJF and LF once belonged to the same source. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…JinQi Jiangtang tablet (JQJTT) is a Chinese patent medicine that has been shown to be beneficial for patients with diabetes both preclinically and clinically; however, the molecular mechanism underlying the effects of JQJTT remains unclear. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Besides, the structure-activity relationship, application prospect and patent application of LPs were analyzed and summarized. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Pfizer and the Medicines Patent Pool (MPP) have reached a voluntary licensing agreement for Paxlovid (nirmatrelvir+ritonavir), a novel antiviral for coronavirus disease 2019 (COVID-19) taken orally in the first 5 days from symptom onset. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: The coexistence with patent ductus arteriosus (PDA), mitral valve prolapse (MVP), atrial fibrillation (AF) and hyperthyroidism is extremely rare and complex. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Thus, targeting TLR-4 to attenuate inflammation and early thrombosis might be a therapeutic approach to keep AVF patent and maintain blood flow through the outflow vein.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…DISCUSSION: CECT scan in over half of the AMI patients may show patent mesenteric vessels. However, such patency of mesenteric vessels should not rule out the possibility of AMI in cases of COVID-19 with prominent GI signs and symptoms, especially those admitted in ICU. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…A general outlook on the approved drugs, recent patents, and current research in this field is herein provided, and the role of the urea moiety in the drug discovery process is discussed form a medicinal chemistry standpoint. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In this manuscript, an effort has been made to review the research on TZD derivatives as potential antimicrobial, antioxidant, and antihyperglycemic agents from the period from 2010 to the present date, along with their molecular mechanisms and the information on patents granted to TZD analogues.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Several physical eye models have been reviewed from peer-reviewed papers and patent applications. A typical eye model includes an artificial cornea, an intraocular lens or other lens to simulate the crystalline lens, an aperture as the pupil, and a posterior retinal surface, which may be connected to a light sensor. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Detailed morphological and functional examinations of the retina revealed that the lesions of the three patients had many similar characteristics, such as macular morphological changes, patent pattern visual monitoring amplitude or peak time abnormalities, multi-fucus electroretinograms macular central amplitude density decreased. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Digital finance reduces CO(2) emissions by promoting energy industrial structure transformation and spreads to surrounding areas through spillover effects, contributes to increasing green patents granted and thus reduces regional CO(2) emissions, advances the green technological progress and therefore inhibits CO(2) emissions, but reduces the green technological progress in surrounding areas and increases CO(2) emissions due to the siphon effect. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…CONCLUSION: Biosimilar use in ophthalmology is expected to grow with the patent expiration of two major anti–vascular endothelial growth factor drugs, ranibizumab and aflibercept, and the development of an ophthalmology-specific bevacizumab biosimilar. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In this review, strategies to produce foods aimed to alleviate food needs before, during and after catastrophic conditions are described based on the supply of various processed, intermediate and low moisture foods and three categories of food supplies are depicted based on the nature of the adverse conditions, Also, relevant patents on on innovative food preparations and containers for disaster areas are discussed. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Analysing artificial networks with patent geometry we discover that, different from current belief, hyperbolic networks do not show in general high GC and efficient greedy navigability (GN) with respect to the geodesics. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…STUDY DESIGN: Intention-to-treat, cohort-controlled study of 106 infants admitted during three alternating epochs of PINDO or Expectant patent ductus arteriosus (PDA) management. RESULTS: At 7–8 days 85% of Expectant Management epoch infants had a moderate/large PDA (median exposure was 23 days). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso